| Literature DB >> 34199664 |
Inés López-Cuenca1,2, Rosa de Hoz1,2,3, Celia Alcántara-Rey1, Elena Salobrar-García1,2,3, Lorena Elvira-Hurtado1, José A Fernández-Albarral1, Ana Barabash4,5, Federico Ramírez-Toraño6,7, Jaisalmer de Frutos-Lucas6,7,8,9, Juan J Salazar1,2,3, Ana I Ramírez1,2,3, José M Ramírez1,2,10.
Abstract
A family history (FH+) of Alzheimer's disease (AD) and ɛ4 allele of the ApoE gene are the main genetic risk factors for developing AD, whereas ɛ4 allele plays a protective role in age-related macular degeneration. Ocular vascular changes have been reported in both pathologies. We analyzed the choroidal thickness using optical coherence tomography (OCT) and the foveal avascular zone (FAZ) using OCT-angiography and compared the results with ApoE gene expression, AD FH+, and the presence or absence of hard drusen (HD) in 184 cognitively healthy subjects. Choroidal thickness was statistically significantly different in the (FH-, ɛ4-, HD+) group compared with (i) both the (FH-, ɛ4-, HD-) and the (FH+, ɛ4+, HD+) groups in the superior and inferior points at 1500 μm, and (ii) the (FH+, ɛ4-, HD+) group in the superior point at 1500 μm. There were statistically significant differences in the superficial FAZ between the (FH+, ɛ4-, HD+) group and (i) the (FH+, ɛ4-, HD-) group and (ii) the (FH+, ɛ4+, HD-) group. In conclusion, ocular vascular changes are not yet evident in participants with a genetic risk of developing AD.Entities:
Keywords: AMD; Alzheimer’s; ApoE ɛ4; OCT; OCTA; choroid; family history; foveal avascular zone; hard drusen; retina
Year: 2021 PMID: 34199664 DOI: 10.3390/biomedicines9060638
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059